Previous Article | Next Article 
Infection and Immunity, July 1999, p. 3242-3247, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Increase in Gamma Interferon-Secreting CD8+, as Well
as CD4+, T Cells in Lungs following Aerosol Infection
with Mycobacterium tuberculosis
Carl G.
Feng,1
Andrew G. D.
Bean,1,
Helena
Hooi,1
Helen
Briscoe,1,2 and
Warwick J.
Britton1,2,*
Centenary Institute of Cancer Medicine and
Cell Biology, Newtown, New South Wales, Australia
2042,1 and Department of Medicine,
University of Sydney, New South Wales, Australia 20062
Received 30 November 1998/Returned for modification 2 February
1999/Accepted 14 April 1999
 |
ABSTRACT |
Although it is well established that CD4+ T cells are
required for the protective immune response against tuberculosis (TB), there is some evidence that CD8+ T cells are also involved
in the host response to Mycobacterium tuberculosis. There is, however, a paucity of information on the pulmonary CD8+ T-cell response during infection. We
therefore have compared the changes in both CD8+ and
CD4+ T cells following aerosol infection with
M. tuberculosis. There was an observed delay between the
peak of infection and the activated T-cell response in the lung. The
kinetics of CD8+ and CD4+ T-cell responses in
the lung were identical, both peaking at week 8, 4 weeks later than the
peak of cellular response in draining lymph nodes. Similar changes
in activation/memory phenotypes occurred on the pulmonary
CD8+ and CD4+ T cells. Following in vitro
restimulation, both subsets synthesized gamma interferon, a cytokine
essential for controlling M. tuberculosis infection. Since
lung CD8+ T cells are actively expanded during aerosol
M. tuberculosis infection, it is important that both
CD8+ and CD4+ T cells be targeted in the design
of future TB vaccines.
 |
INTRODUCTION |
The major protective immune response
against intracellular bacteria, such as Mycobacterium
tuberculosis, is cell-mediated immunity (26). It has
been well established that CD4+ T cells are the
dominant protective T cells (1, 10), but there is
evidence that CD8+ T cells also have a role in the
response against mycobacteria. Mice deficient in CD8+
T cells are unable to control M. tuberculosis infection
(13, 18), and cell transfer experiments have shown that
immune CD8+ as well as CD4+ T cells can
transfer protective immunity (23, 31, 34). Other studies
suggest that CD8+ T cells may contribute to the resolution
of infection by the production of gamma interferon (IFN-
) and
cytolysis of infected cells (11, 30, 40).
Changes in cell surface activation markers define specific phases of
T-cell activation and may distinguish between naive, effector, and
memory T-cell populations (39). Resting naive T cells
express low levels of CD44 and the integrins LFA-1 and VLA-4 and high
levels of CD45RB and CD62L (L-selectin). Upon antigen stimulation,
naive T cells transform to large blastoid cells, and the phenotype
of these effector cells becomes CD44hi LFA-1hi
VLA-4hi CD45RBlo CD62L
(12,
39). Other activation markers such as CD25 and CD69 are also
upregulated (29, 38). The importance of CD4+ T
cells bearing activation/memory markers in expressing effective immune
response against mycobacterial infection has been reported for both
humans and mice (2, 3, 19). Previous studies on the
nature of the cellular infiltrate in murine tuberculosis (TB) have
focused on changes in the spleen after intravenous infection rather
than the lung, the site of natural infection.
We have examined changes in CD8+ as well as
CD4+ T cells in lungs following aerosol infection and
compared them over a 12-week period. Our results show that
CD8+ T cells undergo phenotypic and functional changes
comparable to those in CD4+ T cells during the pulmonary
infection with M. tuberculosis.
 |
MATERIALS AND METHODS |
Mice.
C57BL/6 female mice were supplied by ARC (Perth,
Western Australia, Australia) and were maintained in
specific-pathogen-free conditions at the Centenary Institute animal
facility until infection with M. tuberculosis, when they
were transferred and maintained in a level 3 physical containment
facility. Mice were used between 6 and 8 weeks of age.
Bacteria and aerosol infection.
M. tuberculosis H37Rv
(ATCC 27294) was grown in Proskauer-Beck liquid medium (Difco, Detroit,
Mich.) for 14 days at 37°C. The bacteria were washed and then
enumerated on supplemented Middlebrook 7H11 agar (Difco). Mice were
exposed to M. tuberculosis H37Rv in a Middlebrook airborne
infection apparatus (Glas-Col, Terre Haute, Ind.) at a predetermined
infective dose. Approximately 100 viable bacilli were delivered to the
lungs of each mouse, as determined by culture of lung homogenates
24 h later.
Antibodies.
The following monoclonal antibodies (MAbs) were
used for flow cytometry. Anti-CD44-fluorescein isothiocyanate (FITC),
anti-CD49d (
4 integrin)-FITC, anti-CD69-FITC,
anti-CD45RB-phycoerythrin (PE), anti-CD11a-PE, and anti-
7
integrin-PE were purchased from Pharmingen (San Diego, Calif.).
Anti-CD62-PE, anti-CD4-tricolor, anti-CD8-tricolor, and isotype control
antibodies were purchased from Caltag (San Francisco, Calif.).
Preparation of single-cell suspensions from lung and lymphoid
organs.
Animals were sacrificed by carbon dioxide narcosis. The
lungs were perfused with heparin (Fisons Pharmaceuticals, New South Wales, Australia), 20 U/ml in phosphate-buffered saline. Lung tissues
were minced and then incubated for 90 min at 37°C with shaking in
complete medium (5 ml/lung) supplemented with collagenase I (50 U/ml;
type 4197; Worthington, Freehold, N.J.) and DNase I (13 µg/ml;
Boehringer, Mannheim, Germany). After incubation, a single-cell
suspension was collected by removing large aggregates and debris by
passage though a 100-µm-pore-size mesh. A single-cell suspension from
lymphoid organs was obtained by passing spleens or lymph nodes through
a stainless steel sieve, and erythrocytes in the spleen suspensions
were lysed in a hypotonic buffer.
Cell surface staining and flow cytometry.
Cells were stained
for 20 min on ice then washed in FACS (fluorescence-activated cell
sorting) buffer (2% bovine serum albumin and 0.1% NaN3 in
phosphate-buffered saline). The data were collected by using a FACScan
with CELL-Quest program and analyzed with the same program (Becton
Dickinson, Mountain View, Calif.). Total lymphocyte number was obtained
by multiplying the number of viable cells by the percentage of
lymphocytes as determined by forward and side scatter. The number of
CD4+ and CD8+ T cells was further calculated by
multiplying the number of lymphocytes by percentage of each T-cell
subset. The quantitation of positively stained population was based on
samples stained with isotype control antibodies.
In vitro stimulation of T cells.
Lung cells were prepared by
incubating lung single-cell suspensions in a six-well plate to remove
macrophages. After 1 h of incubation at 37°C, nonadhering cells
(106/ml) were stimulated with plate-bound anti-CD3 MAb (10 µg/ml; Pharmingen) for 16 h in complete RPMI (RPMI 1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine,
10 mM HEPES, 0.5 µM 2-mercaptoethanol, 100 U of penicillin per ml,
and 100 µg of streptomycin per ml).
Intracellular staining for IFN-
.
Brefeldin A (10 µg/ml;
Sigma, St. Louis, Mo.) was added to the culture for the final 4 h
of culture. Cells were washed and surface stained with rat anti-mouse
CD4 or CD8 MAb (Caltag). The cells were fixed and permeabilized by
using a Cytotofix/Cytoperm kit as instructed by the manufacturer
(Pharmingen). Briefly, cells were resuspended in a fix buffer for 20 min at room temperature and then washed with permeabilization buffer.
Cells were then stained with anti-IFN-
-FITC (AN18) in
permeabilization buffer at 4°C for 30 min. Cells were washed in
permeabilization buffer, resuspended in FACS buffer, and analyzed on a
FACScan flow cytometer (Becton Dickinson).
 |
RESULTS |
Kinetics of cellular response in lungs, MLN and spleens.
The
kinetics of T-cell recruitment and proliferation differed between the
three organs. The number of T cells in the lung and mediastinal lymph
nodes (MLN) had increased 5- to 10-fold by 4 weeks postinfection (Fig.
1). This cellular influx in the infected
lung peaked at week 8 and began to declined by week 12. By contrast,
the cell expansion in the MLN peaked earlier at week 4 and was
maintained until 12 weeks postinfection, suggesting that the MLN is the
site of induction for T-cell activation. There was a small, gradual
increase in T-cell number in the spleen over 12 weeks. Both
CD4+ and CD8+ T cells were more abundant, and
there was no preferential accumulation of either subset in the three
organs at the time points examined (Fig. 1).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Kinetics of cellular responses in the lung, MLN, and
spleen. Cell numbers in the lung, MLN, and spleen were examined at 0, 4, 8, and 12 weeks after aerosol M. tuberculosis infection.
Data are presented as the mean and standard error for three mice in one
of two separate experiments. The significance of the differences in
cell number between weeks 4 and 8 postinfection was determined by
unpaired Student's t test. The number of CD4+
and CD8+ T cells in the lung at 8 weeks was significantly
greater (P < 0.05) than at 4 weeks, while there was no
significant difference in the numbers of CD4+ and
CD8+ T cells in MLN between 4 and 8 weeks.
|
|
Changes in activation markers on T cells during infection.
To
investigate whether CD8+ T cells have patterns of
activation markers similar to those of CD4+ T cells, we
compared the levels of expression of activation/homing markers on the
two subsets in the three organs from infected and age-matched control
mice. The proportions of CD4+ and CD8+ T
cells expressing activated phenotypes in the infected lungs were
significantly greater than in control mice, although the changes for
CD8+ T cells were not as dramatic as those for
CD4+ T cells (Fig. 2).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Change in the expression of activation markers on
CD4+ and CD8+ T cells in infected lungs. Cells
isolated from the lung at week 8 postinfection were analyzed by
multiparameter FACS. The histogram profiles show the expression of
activation markers after gating on lymphocytes and CD4+ and
CD8+ T cells. The profiles are representative of three to
six mice. Numbers in the histograms indicate percentages of
CD4+ and CD8+ T cells for each molecule. The
differences between control and infected mice were significant for all
markers analyzed (P < 0.05, unpaired Student's
t test).
|
|
The two subsets exhibited comparable patterns of expression, with few
exceptions. The levels of CD45RB expressed on CD8
+ T cells
were more heterogeneous than those on CD4
+ T cells,
consistent with previous reports (
5,
6). Since

7 has been
implicated as a component of mucosa-related integrin
(
37),
we examined the expression of this molecule in the lungs
of control and
infected mice. In contrast to the majority of CD4
+ T cells,
which expressed low level of

7 integrin, half of the
CD8
+ T cells expressed high levels of

7 in uninfected
lungs. A dramatic
change was observed following infection. While the
majority of
CD4
+ and CD8
+ T cells expressed no
or a low level of

7 integrin, minor populations
of CD4
+
and CD8
+ T cells which expressed higher levels of

7
emerged during infection.
A similar change of

7 did not occur on T
cells in MLN and spleen
throughout the course of infection (data not
shown).
To investigate whether the increase in cell numbers was due to
the preferential accumulation of activated T cells following
infection, activation/memory markers were examined on
CD4
+ and CD8
+ T cells over the course of
infection. Cells which had an upregulated
level of CD69 or which showed
dual expression of CD44
hi and CD45RB
lo markers
were defined as activated cells. There was no significant
difference in
both percentage and absolute number of activated
T cells in lung, MLN,
and spleen between control mice and mice
at 2 weeks postinfection. The
maximum number of organisms (CFU)
in lung was observed at week 4, whereas the number of activated
lung T cells bearing these markers did
not peak until week 8.
The total number of activated lung
CD4
+ and CD8
+ T cells decreased by week 12 (Fig.
3). Compared to the lung,
the
change in the majority of surface markers on T cells in MLN
and
spleens of infected mice was minimal although a substantial
rise in the
absolute number of activated (CD44
hi
CD45RB
lo and CD69
+) CD4
+ and
CD8
+ T cells occurred in MLN (Fig.
4), owing to the increased cellularity
of
MLN following infection (Fig.
1). A significant downregulation
of CD62L, however, occurred on T cells in both infected lungs
and
MLN (Fig.
5), and by week 12 of
infection, more than 90% CD4
+ and 70% of CD8
+
lung T cells had downregulated CD62L.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Delay between the peak of infection (CFU) and
accumulation of activated CD4+ and CD8+ T cells
in infected lungs. The course of infection, expressed as CFU ( ), was
compared with the kinetics of influx of activated T cells. The
expression of CD44hi CD45RBlo ( ) or
CD69+ ( ) was used to define the activated
CD4+ and CD8+ T cells. Data are presented as
the mean and standard error for three mice from one of two separate
experiments.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Change in the expression of activation markers on
CD4+ and CD8+ T cells in MLN. Cells isolated
from the MLN at weeks 2, 4, 8, and 12 postinfection were analyzed by
multiparameter FACS. The expression of CD44hi
CD45RBlo or CD69+ was used to define the
activated CD4+ and CD8+ T cells. Data are
presented as the mean and standard errors for three mice from one of
two separate experiments. The significance of the differences in each
subset between control mice and mice at 2, 4, 8, and 12 weeks
postinfection was determined by unpaired Student's t test.
There were no significant differences in both percentage and absolute
number of activated T cells between control mice and mice at 4, 8, and
12 weeks postinfection. The change in the proportion of activated T
cells in either subset throughout the course of infection was not
statistically different. There was a significant difference in absolute
number of activated T cells between control mice and mice at 4, 8, and
12 weeks postinfection (P < 0.05).
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
Progressive loss of expression of CD62L on both
CD4+ and CD8+ T cells. Cells from lungs and MLN
were harvested at weeks 0, 4, 8, and 12 after aerosol infection. The
CD62L expression on CD4+ and CD8+ T cells was
analyzed after gating on viable lymphocytes. Data are presented as mean
and standard error for three mice in one of two separate experiments.
There were significant differences between control mice and mice at 4, 8, and 12 weeks postinfection in both lungs and MLN (P < 0.05).
|
|
The recruitment of T cells to nonlymphoid tissues such as the lung is
dependent on the interaction between integrins on the
T cells and their
ligands on endothelial cells (
7,
8). We
therefore examined
the expression of CD11a and CD49d, the respective

chains, of LFA-1
and VLA-4 on CD4 and CD8 T cells. Multiparameter
FACS analysis
demonstrated that both markers were upregulated
(Fig.
2), suggesting
the possible involvement of LFA-1-ICAM-1
or -2 and VLA-4-VCAM-1
interactions in the recruitment of activated
T cells into
M. tuberculosis-infected lungs. In agreement with
a previous report
on the changes of activation markers on spleen
CD4
+ T cell
after intravenous infection (
2), CD44
hi
CD45RB
lo pulmonary T cells expressed high levels of CD11a
(Fig.
6). There
was also an accumulation
of CD44
hi and CD11a
hi T cells in infected
lungs.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 6.
Coexpression of CD44 and CD45RB and CD11a on
CD4+ (A) and CD8+ (B) T cells. Cells isolated
from lungs at week 8 after infection were analyzed as described for
Fig. 2. The profiles shown are representative of three mice from one of
two separate experiments. Numbers in the quadrants indicate percentages
of CD4+ and CD8+ T cells.
|
|
Increase in the number of IFN-
-producing T cells in infected
lungs.
To examine the contribution of T cell subsets to IFN-
production, lung cells from normal and infected mice were restimulated with anti-CD3 MAb for 16 h. Throughout the course of infection, the numbers of both CD4+ and CD8+
IFN-
-producing cells were greater in infected lungs than in uninfected lungs (Fig. 7).

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 7.
Recall IFN- production by CD4+ and
CD8+ T cells in infected and uninfected mice. Lung cells
isolated from mice 8 weeks after aerosol infection or from uninfected
control mice were cultured at 106/ml with solid-phase
anti-CD3 MAb for 24 h. Intracellular staining for IFN- was
performed after surface staining of CD4 and CD8 molecules. The profiles
shown are representative of three mice from one of two separate
experiments. Numbers in the quadrants indicate percentages of total
viable lymphocytes.
|
|
 |
DISCUSSION |
While the mouse model has been used extensively to study the
immune response to M. tuberculosis infection, the
phenotype of responding T cells is not fully defined. The majority of
such studies have been conducted in intravenous models of infection (2, 19). After a sublethal intravenous injection of
M. tuberculosis, the number of CD4+ T cells
with CD44hi CD45RBlo phenotype peaked at 2 to 3 weeks in the spleens of infected mice and then gradually declined
(19). In this model, the kinetics of T-cell responses
mirrored the course of infection in the spleen, which peaked at week 3 after intravenous infection. This CD44hi
CD45RBlo population has therefore been suggested to be
involved in protective immune responses. Andersen et al. further
extended this finding by demonstrating the involvement of this
population in the memory CD4+ T-cell response in a
rechallenge model (2). After primary infection, the mice
were treated with chemotherapy and activation markers were
downregulated to the resting state. When these immune mice were
rechallenged with M. tuberculosis, an accelerated
accumulation of CD44hi CD45RBlo
CD4+ T cells occurred, with rapid production of high
levels of IFN-
by this population. However, analysis of changes in
the CD8+ T-cell subset during an aerosol infection with
M. tuberculosis has not been reported. Our study
provides a comprehensive phenotypic and functional study of T-cell
responses in the M. tuberculosis-infected lung, which
is the primary site of natural infection.
The evidence presented here reveals similarities and differences
between aerosol and intravenous models. In agreement with the pattern
in spleen after intravenous injection, an expansion of activated
CD4+ T cells developed in the lungs, and we further
demonstrated that similar changes also occurred among the
CD8+ T-cell subset (Fig. 2). A striking difference was the
delay between the peak of infection and the activated T-cell response
in the lung (Fig. 3). Several factors may be responsible for the
differences between the aerosol and intravenous models. First, the size
of the inoculum varies, as a higher dose of the bacteria is usually used in the intravenous model. The lower number of organisms delivered by the aerosol route may be less immunogenic than the higher number given by intravenous infection (33). Second, the levels of
efficiency of the control of intracellular infection and subsequent
presentation of mycobacterial antigens by macrophages in the lung and
spleen may be different (33). Finally, the quantity and
nature of professional antigen-presenting cells may vary between the
lung and spleen (21). A similar pattern of T-cell responses
in the lung and MLN was also observed in an aerosol M. bovis BCG infection model (34a).
In contrast to a previous report that the CD8+ T-cell
response in the intravenous model peaked later than the
CD4+ T cell response (34), the kinetics of
CD4+ and CD8+ T-cell responses in the lung
appeared similar, both peaking around week 8 of infection. Therefore,
as with CD4+ T cells, CD8+ T cells can be
primed and activated during M. tuberculosis infection. This activation led to the phenotypic changes observed on the CD8+ cells. The resulting upregulation of activation/homing
markers may allow these activated CD8+ T cells to
accumulate at the site of inflammation. We cannot rule out that some
degree of bystander activation for CD8+ T cells may have
occurred, but it is unlikely that nonspecific activation accounts for
the majority of activated CD8+ T cells present in the lung.
In a model of lymphocytic choriomeningitis virus infection, 50 to 70%
of the activated CD8+ T cells were antigen specific
(32). This finding questions the traditional view of the
magnitude of the bystander effects (41).
In mice, the inhibition of mycobacterial growth by macrophages
activated by IFN-
has been well established (16, 17, 35). CD8+ T cells from IFN-
-deficient mice failed to transfer
protective immunity against M. tuberculosis infection,
demonstrating IFN-
was essential for CD8+
T-cell-mediated protective immunity (40). Following anti-CD3 stimulation in vitro, which has previously been shown to activate cytokine production from in vivo-primed cells (9, 14, 15, 28), the number of IFN-
-producing CD4+ and
CD8+ T cells from M. tuberculosis-infected
lungs was greater than that in uninfected lungs (Fig. 7); this result
indicates that both subsets appeared primed and predisposed to produce
IFN-
, a crucial cytokine for the protective immunity against
mycobacterial infection.
CD62L has been widely used in the study of T-cell trafficking, and
activated CD62L
T cells have been shown to migrate to
sites of inflammation. It has been suggested that the majority of
virus-specific cytotoxic T-lymphocyte precursors generated in MLN were
CD62L
, and they differentiated into cytotoxic
T-lymphocyte effectors after migrating to the site of infection
(22). At week 12 after aerosol M. tuberculosis infection, the expression of this marker on both
CD4+ and CD8+ T cells was downregulated in the
lung (Fig. 4), suggesting that there was an accumulation of
activated/memory T cells in the local tissue. Interestingly, the
percentage of CD62L
T cells in MLN also began to rise at
the later stage of the infection. This may result from local T-cell
activation due to the spread of infection to MLN or homing of a
population of memory cells to the local lymph nodes. The binding of the
CD62L
population to high endothelial venules in the lymph
nodes is probably mediated by LFA-1 (20).
TB is a chronic infectious disease characterized by the infiltration of
lymphocytes to inflamed tissues. Integrins have a major role in
leukocyte-endothelial cell interactions which are important for
migration of activated T cells to nonlymphoid tissues (7,
8). The T-cell homing to local tissues mediated by the integrins LFA-1 and VLA-4 has been demonstrated in many chronic inflammatory situations, such as inflamed skin (25),
arthritic joints (24, 36), and glomerulonephritis
(27). The expansion of CD11ahi and
CD49dhi T cells in lung observed in this study (Fig. 2)
suggests that these integrins may also contribute to the recruitment of
activated T cells to inflamed lungs. Similar to the data presented
here, CD44hi LFA-1hi T cells also expanded
dramatically in lung during an influenza virus infection
(4). The expansion of the T-cell population correlated with
increased cytokine production in that model (4), suggesting
that these cells may well be the major cytokine-producing cells in the
M. tuberculosis-infected lung.
In conclusion, both CD4+ and CD8+ T cells
respond to M. tuberculosis infection in the lung, with
maximal activation and expansion of both subsets observed 4 weeks after
the peak of infection. The CD8+ T-cell response is
comparable to that of CD4+ T cells, both phenotypically and
functionally, suggesting that CD8+ T cells contribute to
the protective immune response against M. tuberculosis.
The potential effects of CD8+ T cells warrant strategies
for stimulating them in the design of future TB vaccines.
 |
ACKNOWLEDGMENTS |
This work was supported by the National Health and Medical
Research Council of Australia. C.G.F. and H.H. are recipients of Australian postgraduate awards.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Centenary
Institute of Cancer Medicine and Cell Biology, Locked Bag No. 6, Newtown, NSW, Australia 2042. Phone: 61-2-9515 5210. Fax: 61-2-9351 3968. E-mail: wbritton{at}medicine.usyd.edu.au.
Present address: CSIRO, Division of Animal Health, Geelong,
Victoria, Australia 3220.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Andersen, P.
1997.
Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.
Scand. J. Immunol.
45:115-131[Medline].
|
| 2.
|
Andersen, P.,
A. B. Andersen,
A. L. Sorensen, and S. Nagai.
1995.
Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.
J. Immunol.
154:3359-3372[Abstract].
|
| 3.
|
Barnes, P. F.,
S. D. Mistry,
C. L. Cooper,
C. Pirmez,
T. H. Rea, and R. L. Modlin.
1989.
Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis.
J. Immunol.
142:1114-1119[Abstract].
|
| 4.
|
Baumgarth, N.,
M. Egerton, and A. Kelso.
1997.
Activated T cells from draining lymph nodes and an effector site differ in their responses to TCR stimulation.
J. Immunol.
159:1182-1191[Abstract].
|
| 5.
|
Baumgarth, N., and A. Kelso.
1996.
Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection.
Eur. J. Immunol.
26:2189-2197[Medline].
|
| 6.
|
Birkeland, M. L.,
P. Johnson,
I. S. Trowbridge, and E. Pure.
1989.
Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation.
Proc. Natl. Acad. Sci. USA
86:6734-6738[Abstract/Free Full Text].
|
| 7.
|
Bradley, L. M., and S. R. Watson.
1996.
Lymphocyte migration into tissue: the paradigm derived from CD4 subsets.
Curr. Opin. Immunol.
8:312-20[Medline].
|
| 8.
|
Butcher, E. C., and L. J. Picker.
1996.
Lymphocyte homing and homeostasis.
Science
272:60-66[Abstract].
|
| 9.
|
Christensen, J. P.,
J. P. Stenvang,
O. Marker, and A. R. Thomsen.
1996.
Characterization of virus-primed CD8+ T cells with a type 1 cytokine profile.
Int. Immunol.
8:1453-1461[Abstract/Free Full Text].
|
| 10.
|
Cooper, A. M., and J. L. Flynn.
1995.
The protective immune response to Mycobacterium tuberculosis.
Curr. Opin. Immunol.
7:512-516[Medline].
|
| 11.
|
De Libero, G.,
I. Flesch, and S. H. Kaufmann.
1988.
Mycobacteria-reactive Lyt-2+ T cell lines.
Eur. J. Immunol.
18:59-66[Medline].
|
| 12.
|
Doherty, P. C.
1996.
Cytotoxic T cell effector and memory function in viral immunity.
Curr. Top. Microbiol. Immunol.
206:1-14[Medline].
|
| 13.
|
D'Sousa, C. D.,
A. M. Cooper,
A. A. Frunk, and I. M. Orme.
1998.
The role of CD8 cells in acquired immunity and pulmonary tuberculosis in the mouse models, p. 47. TB molecular methods and immunological aspects.
Keystone Symposia, Silverthorne, Colo.
|
| 14.
|
Dubey, C.,
M. Croft, and S. L. Swain.
1996.
Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals.
J. Immunol.
157:3280-3289[Abstract].
|
| 15.
|
Emoto, M.,
Y. Emoto, and S. H. Kaufmann.
1997.
Bacille Calmette Guerin and interleukin-12 down-modulate interleukin-4-producing CD4+ NK1+ T lymphocytes.
Eur. J. Immunol.
27:183-188[Medline].
|
| 16.
|
Fenton, M. J.,
M. W. Vermeulen,
S. Kim,
M. Burdick,
R. M. Strieter, and H. Kornfeld.
1997.
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis.
Infect. Immun.
65:5149-5156[Abstract/Free Full Text].
|
| 17.
|
Flesch, I., and S. H. Kaufmann.
1987.
Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.
J. Immunol.
138:4408-4413[Abstract].
|
| 18.
|
Flynn, J. L.,
M. M. Goldstein,
K. J. Triebold,
B. Koller, and B. R. Bloom.
1992.
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
Proc. Natl. Acad. Sci. USA
89:12013-12017[Abstract/Free Full Text].
|
| 19.
|
Griffin, J. P., and I. M. Orme.
1994.
Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis.
Infect. Immun.
62:1683-1690[Abstract/Free Full Text].
|
| 20.
|
Hamann, A.,
D. Jablonski-Westrich,
A. Duijvestijn,
E. C. Butcher,
H. Baisch,
R. Harder, and H. G. Thiele.
1988.
Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing.
J. Immunol.
140:693-699[Abstract].
|
| 21.
|
Holt, P. G.,
J. Oliver,
N. Bilyk,
C. McMenamin,
P. G. McMenamin,
G. Kraal, and T. Thepen.
1993.
Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages.
J. Exp. Med.
177:397-407[Abstract/Free Full Text].
|
| 22.
|
Hou, S., and P. C. Doherty.
1993.
Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype.
J. Immunol.
150:5494-5500[Abstract].
|
| 23.
|
Hubbard, R. D.,
C. M. Flory, and F. M. Collins.
1991.
Memory T-cell-mediated resistance to Mycobacterium tuberculosis infection in innately susceptible and resistant mice.
Infect. Immun.
59:2012-2016[Abstract/Free Full Text].
|
| 24.
|
Iigo, Y.,
T. Takashi,
T. Tamatani,
M. Miyasaka,
T. Higashida,
H. Yagita,
K. Okumura, and W. Tsukada.
1991.
ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats.
J. Immunol.
147:4167-4171[Abstract].
|
| 25.
|
Issekutz, T. B.
1992.
Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1.
J. Immunol.
149:3394-3402[Abstract].
|
| 26.
|
Kaufmann, S. H.
1995.
Immunity to intracellular microbial pathogens.
Immunol. Today
16:338-342[Medline].
|
| 27.
|
Kawasaki, K.,
E. Yaoita,
T. Yamamoto,
T. Tamatani,
M. Miyasaka, and I. Kihara.
1993.
Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis.
J. Immunol.
150:1074-1083[Abstract].
|
| 28.
|
Kelso, A.
1990.
Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
J. Immunol.
145:2167-2176[Abstract].
|
| 29.
|
Leonard, W. J.,
J. R. Gnarra,
M. Napolitano, and M. Sharon.
1990.
Structure, function, and regulation of the interleukin-2 receptor and identification of a novel immune activation gene.
Philos. Trans. R. Soc. Lond. Ser. B
327:187-192[Medline].
|
| 30.
|
Mohagheghpour, N.,
D. Gammon,
L. M. Kawamura,
A. van Vollenhoven,
C. J. Benike, and E. G. Engleman.
1998.
CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein.
J. Immunol.
161:2400-2406[Abstract/Free Full Text].
|
| 31.
|
Muller, I.,
S. P. Cobbold,
H. Waldmann, and S. H. Kaufmann.
1987.
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.
Infect. Immun.
55:2037-2041[Abstract/Free Full Text].
|
| 32.
|
Murali-Krishna, K.,
J. D. Altman,
M. Suresh,
D. J. Sourdive,
A. J. Zajac,
J. D. Miller,
J. Slansky, and R. Ahmed.
1998.
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
Immunity
8:177-187[Medline].
|
| 33.
|
North, R. J.
1995.
Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route.
J. Infect. Dis.
172:1550-1553[Medline].
|
| 34.
|
Orme, I. M.
1987.
The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.
J. Immunol.
138:293-298[Abstract].
|
| 34a.
| Palendira, U. Personal communication.
|
| 35.
|
Rook, G. A.,
J. Steele,
M. Ainsworth, and B. R. Champion.
1986.
Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.
Immunology
59:333-338[Medline].
|
| 36.
|
Salmi, M.,
D. P. Andrew,
E. C. Butcher, and S. Jalkanen.
1995.
Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms.
J. Exp. Med.
181:137-149[Abstract/Free Full Text].
|
| 37.
|
Shaw, S. K., and M. B. Brenner.
1995.
The beta 7 integrins in mucosal homing and retention.
Semin. Immunol.
7:335-342[Medline].
|
| 38.
|
Swain, S. L., and L. M. Bradley.
1992.
Helper T cell memory: more questions than answers.
Semin. Immunol.
4:59-68[Medline].
|
| 39.
|
Swain, S. L.,
M. Croft,
C. Dubey,
L. Haynes,
P. Rogers,
X. Zhang, and L. M. Bradley.
1996.
From naive to memory T cells.
Immunol. Rev.
150:143-167[Medline].
|
| 40.
|
Tascon, R. E.,
E. Stavropoulos,
K. V. Lukacs, and M. J. Colston.
1998.
Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon.
Infect. Immun.
66:830-834[Abstract/Free Full Text].
|
| 41.
|
Tough, D. F., and J. Sprent.
1996.
Viruses and T cell turnover: evidence for bystander proliferation.
Immunol. Rev.
150:129-142[Medline].
|
Infection and Immunity, July 1999, p. 3242-3247, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bansal, K., Elluru, S. R., Narayana, Y., Chaturvedi, R., Patil, S. A., Kaveri, S. V., Bayry, J., Balaji, K. N.
(2010). PE_PGRS Antigens of Mycobacterium tuberculosis Induce Maturation and Activation of Human Dendritic Cells. J. Immunol.
184: 3495-3504
[Abstract]
[Full Text]
-
Ryan, A. A., Nambiar, J. K., Wozniak, T. M., Roediger, B., Shklovskaya, E., Britton, W. J., Fazekas de St. Groth, B., Triccas, J. A.
(2009). Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection. J. Immunol.
182: 7172-7177
[Abstract]
[Full Text]
-
Di Liberto, D., Locati, M., Caccamo, N., Vecchi, A., Meraviglia, S., Salerno, A., Sireci, G., Nebuloni, M., Caceres, N., Cardona, P.-J., Dieli, F., Mantovani, A.
(2008). Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. JEM
205: 2075-2084
[Abstract]
[Full Text]
-
Billeskov, R., Vingsbo-Lundberg, C., Andersen, P., Dietrich, J.
(2007). Induction of CD8 T Cells against a Novel Epitope in TB10.4: Correlation with Mycobacterial Virulence and the Presence of a Functional Region of Difference-1. J. Immunol.
179: 3973-3981
[Abstract]
[Full Text]
-
Murray, R. A., Mansoor, N., Harbacheuski, R., Soler, J., Davids, V., Soares, A., Hawkridge, A., Hussey, G. D., Maecker, H., Kaplan, G., Hanekom, W. A.
(2006). Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8+ T Cell Response. J. Immunol.
177: 5647-5651
[Abstract]
[Full Text]
-
Bitsaktsis, C., Winslow, G.
(2006). Fatal Recall Responses Mediated by CD8 T cells during Intracellular Bacterial Challenge Infection. J. Immunol.
177: 4644-4651
[Abstract]
[Full Text]
-
Maue, A. C., Waters, W. R., Davis, W. C., Palmer, M. V., Minion, F. C., Estes, D. M.
(2005). Analysis of Immune Responses Directed toward a Recombinant Early Secretory Antigenic Target Six-Kilodalton Protein-Culture Filtrate Protein 10 Fusion Protein in Mycobacterium bovis-Infected Cattle. Infect. Immun.
73: 6659-6667
[Abstract]
[Full Text]
-
Irwin, S. M., Izzo, A. A., Dow, S. W., Skeiky, Y. A. W., Reed, S. G., Alderson, M. R., Orme, I. M.
(2005). Tracking Antigen-Specific CD8 T Lymphocytes in the Lungs of Mice Vaccinated with the Mtb72F Polyprotein. Infect. Immun.
73: 5809-5816
[Abstract]
[Full Text]
-
Saunders, B. M., Tran, S., Ruuls, S., Sedgwick, J. D., Briscoe, H., Britton, W. J.
(2005). Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection. J. Immunol.
174: 4852-4859
[Abstract]
[Full Text]
-
Feng, C. G., Jankovic, D., Kullberg, M., Cheever, A., Scanga, C. A., Hieny, S., Caspar, P., Yap, G. S., Sher, A.
(2005). Maintenance of Pulmonary Th1 Effector Function in Chronic Tuberculosis Requires Persistent IL-12 Production. J. Immunol.
174: 4185-4192
[Abstract]
[Full Text]
-
Kamath, A. B., Woodworth, J., Xiong, X., Taylor, C., Weng, Y., Behar, S. M.
(2004). Cytolytic CD8+ T Cells Recognizing CFP10 Are Recruited to the Lung after Mycobacterium tuberculosis Infection. JEM
200: 1479-1489
[Abstract]
[Full Text]
-
Scott Algood, H. M., Flynn, J. L.
(2004). CCR5-Deficient Mice Control Mycobacterium tuberculosis Infection despite Increased Pulmonary Lymphocytic Infiltration. J. Immunol.
173: 3287-3296
[Abstract]
[Full Text]
-
Kipnis, A., Basaraba, R. J., Turner, J., Orme, I. M.
(2003). Increased neutrophil influx but no impairment of protective immunity to tuberculosis in mice lacking the CD44 molecule. J. Leukoc. Biol.
74: 992-997
[Abstract]
[Full Text]
-
Villarreal-Ramos, B., McAulay, M., Chance, V., Martin, M., Morgan, J., Howard, C. J.
(2003). Investigation of the Role of CD8+ T Cells in Bovine Tuberculosis In Vivo. Infect. Immun.
71: 4297-4303
[Abstract]
[Full Text]
-
Tobian, A. A. R., Potter, N. S., Ramachandra, L., Pai, R. K., Convery, M., Boom, W. H., Harding, C. V.
(2003). Alternate Class I MHC Antigen Processing Is Inhibited by Toll-Like Receptor Signaling Pathogen-Associated Molecular Patterns: Mycobacterium tuberculosis 19-kDa Lipoprotein, CpG DNA, and Lipopolysaccharide. J. Immunol.
171: 1413-1422
[Abstract]
[Full Text]
-
Majorov, K. B., Lyadova, I. V., Kondratieva, T. K., Eruslanov, E. B., Rubakova, E. I., Orlova, M. O., Mischenko, V. V., Apt, A. S.
(2003). Different Innate Ability of I/St and A/Sn Mice To Combat Virulent Mycobacterium tuberculosis: Phenotypes Expressed in Lung and Extrapulmonary Macrophages. Infect. Immun.
71: 697-707
[Abstract]
[Full Text]
-
Waters, W. R., Rahner, T. E., Palmer, M. V., Cheng, D., Nonnecke, B. J., Whipple, D. L.
(2003). Expression of L-Selectin (CD62L), CD44, and CD25 on Activated Bovine T Cells. Infect. Immun.
71: 317-326
[Abstract]
[Full Text]
-
Dieli, F., Ivanyi, J., Marsh, P., Williams, A., Naylor, I., Sireci, G., Caccamo, N., Di Sano, C., Salerno, A.
(2003). Characterization of Lung {gamma}{delta} T Cells Following Intranasal Infection with Mycobacterium bovis Bacillus Calmette-Guerin. J. Immunol.
170: 463-469
[Abstract]
[Full Text]
-
Lewinsohn, D. A., Lines, R. A., Lewinsohn, D. M.
(2002). Human Dendritic Cells Presenting Adenovirally Expressed Antigen Elicit Mycobacterium tuberculosis-Specific CD8+ T Cells. Am. J. Respir. Crit. Care Med.
166: 843-848
[Abstract]
[Full Text]
-
Roach, D. R., Bean, A. G. D., Demangel, C., France, M. P., Briscoe, H., Britton, W. J.
(2002). TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection. J. Immunol.
168: 4620-4627
[Abstract]
[Full Text]
-
Palendira, U., Bean, A. G. D., Feng, C. G., Britton, W. J.
(2002). Lymphocyte Recruitment and Protective Efficacy against Pulmonary Mycobacterial Infection Are Independent of the Route of Prior Mycobacterium bovis BCG Immunization. Infect. Immun.
70: 1410-1416
[Abstract]
[Full Text]
-
Mannering, S. I., Cheers, C.
(2002). Interleukin-2 and Loss of Immunity in Experimental Mycobacterium avium Infection. Infect. Immun.
70: 27-35
[Abstract]
[Full Text]
-
Serbina, N. V., Lazarevic, V., Flynn, J. L.
(2001). CD4+ T Cells Are Required for the Development of Cytotoxic CD8+ T Cells During Mycobacterium tuberculosis Infection. J. Immunol.
167: 6991-7000
[Abstract]
[Full Text]
-
Serbina, N. V., Flynn, J. L.
(2001). CD8+ T Cells Participate in the Memory Immune Response to Mycobacterium tuberculosis. Infect. Immun.
69: 4320-4328
[Abstract]
[Full Text]
-
Xing, Z., Zganiacz, A., Wang, J., Sharma, S. K.
(2001). Enhanced Protection Against Fatal Mycobacterial Infection in SCID Beige Mice by Reshaping Innate Immunity with IFN-{{gamma}} Transgene. J. Immunol.
167: 375-383
[Abstract]
[Full Text]
-
Chun, T., Serbina, N. V., Nolt, D., Wang, B., Chiu, N. M., Flynn, J. L., Wang, C.-R.
(2001). Induction of M3-Restricted Cytotoxic T Lymphocyte Responses by N-Formylated Peptides Derived from Mycobacterium tuberculosis. JEM
193: 1213-1220
[Abstract]
[Full Text]
-
Feng, C. G., Demangel, C., Kamath, A. T., Macdonald, M., Britton, W. J.
(2001). Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8+ T cells with specificity for a novel mycobacterial epitope. Int Immunol
13: 451-458
[Abstract]
[Full Text]
-
Gonzalez-Juarrero, M., Turner, O. C., Turner, J., Marietta, P., Brooks, J. V., Orme, I. M.
(2001). Temporal and Spatial Arrangement of Lymphocytes within Lung Granulomas Induced by Aerosol Infection with Mycobacterium tuberculosis. Infect. Immun.
69: 1722-1728
[Abstract]
[Full Text]
-
Turner, J., D'Souza, C. D., Pearl, J. E., Marietta, P., Noel, M., Frank, A. A., Appelberg, R., Orme, I. M., Cooper, A. M.
(2001). CD8- and CD95/95L-Dependent Mechanisms of Resistance in Mice with Chronic Pulmonary Tuberculosis. Am. J. Respir. Cell Mol. Bio.
24: 203-209
[Abstract]
[Full Text]
-
Roach, D. R., Briscoe, H., Saunders, B., France, M. P., Riminton, S., Britton, W. J.
(2001). Secreted Lymphotoxin-{alpha} Is Essential for the Control of an Intracellular Bacterial Infection. JEM
193: 239-246
[Abstract]
[Full Text]
-
Lewinsohn, D. M., Zhu, L., Madison, V. J., Dillon, D. C., Fling, S. P., Reed, S. G., Grabstein, K. H., Alderson, M. R.
(2001). Classically Restricted Human CD8+ T Lymphocytes Derived from Mycobacterium tuberculosis-Infected Cells: Definition of Antigenic Specificity. J. Immunol.
166: 439-446
[Abstract]
[Full Text]
-
Smith, S. M., Brookes, R., Klein, M. R., Malin, A. S., Lukey, P. T., King, A. S., Ogg, G. S., Hill, A. V. S., Dockrell, H. M.
(2000). Human CD8+ CTL Specific for the Mycobacterial Major Secreted Antigen 85A. J. Immunol.
165: 7088-7095
[Abstract]
[Full Text]
-
Lyadova, I. V., Eruslanov, E. B., Khaidukov, S. V., Yeremeev, V. V., Majorov, K. B., Pichugin, A. V., Nikonenko, B. V., Kondratieva, T. K., Apt, A. S.
(2000). Comparative Analysis of T Lymphocytes Recovered from the Lungs of Mice Genetically Susceptible, Resistant, and Hyperresistant to Mycobacterium tuberculosis-Triggered Disease. J. Immunol.
165: 5921-5931
[Abstract]
[Full Text]
-
Briscoe, H., Roach, D. R., Meadows, N., Rathjen, D., Britton, W. J.
(2000). A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice. J. Leukoc. Biol.
68: 538-544
[Abstract]
[Full Text]
-
Lewinsohn, D. M., Briden, A. L., Reed, S. G., Grabstein, K. H., Alderson, M. R.
(2000). Mycobacterium tuberculosis-Reactive CD8+ T Lymphocytes: The Relative Contribution of Classical Versus Nonclassical HLA Restriction. J. Immunol.
165: 925-930
[Abstract]
[Full Text]
-
Serbina, N. V., Liu, C.-C., Scanga, C. A., Flynn, J. L.
(2000). CD8+ CTL from Lungs of Mycobacterium tuberculosis-Infected Mice Express Perforin In Vivo and Lyse Infected Macrophages. J. Immunol.
165: 353-363
[Abstract]
[Full Text]
-
Martin, E., Kamath, A. T., Triccas, J. A., Britton, W. J.
(2000). Protection against Virulent Mycobacterium avium Infection following DNA Vaccination with the 35-Kilodalton Antigen Is Accompanied by Induction of Gamma Interferon-Secreting CD4+ T Cells. Infect. Immun.
68: 3090-3096
[Abstract]
[Full Text]
-
Feng, C. G., Britton, W. J., Palendira, U., Groat, N. L., Briscoe, H., Bean, A. G. D.
(2000). Up-Regulation of VCAM-1 and Differential Expansion of {beta} Integrin-Expressing T Lymphocytes Are Associated with Immunity to Pulmonary Mycobacterium tuberculosis Infection. J. Immunol.
164: 4853-4860
[Abstract]
[Full Text]